“How can we have the biggest impact globally?”
Vascular disease is the leading cause of death worldwide. Currently symptoms do not appear until the late stages, often when it is too late. Two PhD students, John Carroll & Eamonn Colley made a breakthrough discovery that enables a radically earlier diagnosis.
They founded Vexev to create an affordable health service that maps the vascular systems of customers, observes how it changes over time, and alerts doctors if something is about to go wrong. This technology has the potential to impact millions of people, transcending humanity beyond vascular disease. In this episode, you’ll learn about the initial research that led to Vexev, the size of the problem John and Eamonn are solving, and why Tip Piumsomboon was convinced to invest in their idea.
Episodes air every second Wednesday/Thursday at 5:30 am. Don't forget to subscribe.
Episode interviewees: Vexev co-founders John Carroll, Eamonn Colley and Blackbird Principal Tip Piumsomboon.
Key topics covered:
- How John and Eamonn went from academics to entrepreneurs
- The changing healthcare landscape
- Proactive, not reactive, medical treatment
The best of John and Eamonn:
- “We were PHD students: running a company and even working out how to email was new to us.”
- "“If we're tracking the coronary arteries over time, things like heart attacks are no longer these sudden events, it's actually a long, slow development over time.”
- "This is happening and we're completely blind to it. We just wait until it's so bad of a problem that the patient is taken into the emergency room.”
- "If our system can work in those remote communities in the middle of outback Australia, we're very confident that they're going to be able to work a